Literature DB >> 27885307

Epidemiology of Testicular Cancer in Oklahoma and the United States.

Shannon Smith, Amanda Janitz, Janis Campbell.   

Abstract

Testicular cancer is a rare cause of morbidity and mortality in the US. Marked disparities in the development of this cancer exist, with testicular cancer being more common in Caucasian men and men of higher socioeconomic status. The incidence of testicular cancer is increasing worldwide, and the reasons for this have not been well documented. It has been proposed that this increase may be due to highly prevalent environmental factors, or from exposure to polychlorinated biphenyls, polyvinyl chloride, cigarette smoking, and tetrahydrocannabinol (THC). For our analysis, data were obtained from the Oklahoma Central Cancer Registry and the Surveillance, Epidemiology and End Results program. Age-adjusted incidence rates and five-year relative survival were calculated for Oklahoma and for the US. Overall, incidence was lower in Oklahoma than the US, but no differences were observed between the US and Oklahoma regarding survival by year of diagnosis, race, age, and stage.

Entities:  

Mesh:

Year:  2016        PMID: 27885307      PMCID: PMC5119752     

Source DB:  PubMed          Journal:  J Okla State Med Assoc        ISSN: 0030-1876


  21 in total

1.  Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult leydig cell differentiation.

Authors:  Giovanna Cacciola; Teresa Chioccarelli; Ken Mackie; Rosaria Meccariello; Catherine Ledent; Silvia Fasano; Riccardo Pierantoni; Gilda Cobellis
Journal:  Biol Reprod       Date:  2008-07-09       Impact factor: 4.285

2.  Testicular cancer and occupational exposures with a focus on xenoestrogens in polyvinyl chloride plastics.

Authors:  C G Ohlson; L Hardell
Journal:  Chemosphere       Date:  2000 May-Jun       Impact factor: 7.086

3.  Testicular cancer patterns in African-American men.

Authors:  Varun K Gajendran; Mike Nguyen; Lars M Ellison
Journal:  Urology       Date:  2005-09       Impact factor: 2.649

4.  Testicular cancer, occupation and exposure to chemical agents among Finnish men in 1971-1995.

Authors:  Johannes Guo; Eero Pukkala; Pentti Kyyrönen; Marja-Liisa Lindbohm; Pirjo Heikkilä; Timo Kauppinen
Journal:  Cancer Causes Control       Date:  2005-03       Impact factor: 2.506

5.  International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.

Authors:  B Trabert; J Chen; S S Devesa; F Bray; K A McGlynn
Journal:  Andrology       Date:  2014-10-20       Impact factor: 3.842

6.  Trends in Testicular Cancer Survival: A Large Population-based Analysis.

Authors:  Wilson Sui; David C Morrow; Carlos E Bermejo; Nicholas J Hellenthal
Journal:  Urology       Date:  2015-06       Impact factor: 2.649

7.  Decreased survival of black Americans with testicular cancer.

Authors:  P J Bridges; R Sharifi; A Razzaq; P Guinan
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

Review 8.  Increasing incidence of testicular cancer worldwide: a review.

Authors:  Eric Huyghe; Tomohiro Matsuda; Patrick Thonneau
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

9.  Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data.

Authors:  Charlotte Le Cornet; Joannie Lortet-Tieulent; David Forman; Rémi Béranger; Aude Flechon; Béatrice Fervers; Joachim Schüz; Freddie Bray
Journal:  Eur J Cancer       Date:  2013-12-23       Impact factor: 9.162

10.  Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms.

Authors:  A H Rimpelä; E I Pukkala
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

View more
  1 in total

1.  Fertility in testicular cancer patients: a single-centre study in Turkey.

Authors:  Mürvet Artuk Uçar; Fatma Arikan; Hasan Şenol Coşkun; Yasemin Kondak; Ali Murat Tatlı; Sema Sezgin Göksu
Journal:  Int J Clin Oncol       Date:  2019-08-26       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.